- Home
- ARVN vs JBI Comparison
ARVN vs JBI Comparison
Compare ARVN & JBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | JBI |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 923.2M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARVN | JBI |
|---|---|---|
| Price | $12.24 | $7.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 23 | 3 |
| Target Price | ★ $18.14 | $10.17 |
| AVG Volume (30 Days) | 792.5K | ★ 1.4M |
| Earning Date | 02-10-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.34 |
| Revenue | $312,300,000.00 | ★ $888,700,000.00 |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | N/A | $1.58 |
| P/E Ratio | ★ N/A | $21.13 |
| Revenue Growth | ★ 93.86 | N/A |
| 52 Week Low | $5.90 | $5.73 |
| 52 Week High | $20.38 | $10.80 |
Technical Indicators
Market Signals| Indicator | ARVN | JBI |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 61.29 |
| Support Level | $11.88 | $6.83 |
| Resistance Level | $12.79 | $7.18 |
| Average True Range (ATR) | 0.53 | 0.22 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 68.02 | 94.56 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.